Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 19:38:101279.
doi: 10.1016/j.conctc.2024.101279. eCollection 2024 Apr.

Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the "power training in older multiple sclerosis patients (PoTOMS) randomized control trial

Tobias Gaemelke  1 , Christoffer Laustsen  2 , Peter Feys  3 , Lars Folkestad  4 , Marianne Skovsager Andersen  4 , Niklas Rye Jørgensen  5   6 , Marie-Louise Jørgensen  7 , Sune Nørhøj Jespersen  8   9 , Steffen Ringgaard  2 , Simon F Eskildsen  9 , Ulrik Dalgas  1 , Lars G Hvid  1   10
Affiliations

Effects of power training in older patients with multiple sclerosis on neurodegeneration, neuromuscular function, and physical function. A study protocol for the "power training in older multiple sclerosis patients (PoTOMS) randomized control trial

Tobias Gaemelke et al. Contemp Clin Trials Commun. .

Abstract

Introduction: Approximately one-third of all persons with multiple sclerosis (pwMS) are older, i.e., having an age ≥60 years. Whilst ageing and MS separately elicit deteriorating effects on brain morphology, neuromuscular function, and physical function, the combination of ageing and MS may pose a particular challenge. To counteract such detrimental changes, power training (i.e., a type of resistance exercise focusing on moderate-to-high loading at maximal intended movement velocity) presents itself as a viable and highly effective solution. Power training is known to positively impact physical function, neuromuscular function, as well as brain morphology. Existing evidence is promising but limited to young and middle-aged pwMS, with the effects of power training remaining to be elucidated in older pwMS.

Methods: The presented 'Power Training in Older MS patients (PoTOMS)' trial is a national, multi-center, parallel-group, randomized controlled trial. The trial compares 24 weeks of usual care(n = 30) to 24 weeks of usual care and power training (n = 30). The primary outcome is whole brain atrophy rate. The secondary outcomes include changes in brain micro and macro structures, neuromuscular function, physical function, cognitive function, bone health, and patient-reported outcomes.

Ethics and dissemination: The presented study is approved by The Regional Ethics Committee (reference number 1-10-72-222-20) and registered at the Danish Data Protection Agency (reference number 2016-051-000001). All study findings will be published in scientific peer-reviewed journals and presented at relevant scientific conferences independent of the results. The www.clinicaltrials.gov identifier is NCT04762342.

Keywords: Multiple sclerosis; aging; neuroprotection; resistance exercise.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Study design of the PoTOMS trial.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Compston A., Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517. - PubMed
    1. Filippi M., Rocca M.A., Barkhof F., Brück W., Chen J.T., Comi G., et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol. 2012;11(4):349–360. - PubMed
    1. The Multiple Sclerosis International Federation Atlas of MS. third ed. September 2020.
    1. Amankwah N., Marrie R.A., Bancej C., Garner R., Manuel D.G., Wall R., et al. Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts. Health Promot Chronic Dis Prev Can. 2017;37(2):37–48. - PMC - PubMed
    1. Vaughn C.B., Jakimovski D., Kavak K.S., Ramanathan M., Benedict R.H.B., Zivadinov R., et al. Epidemiology and treatment of multiple sclerosis in elderly populations. Nat. Rev. Neurol. 2019;15(6):329–342. - PubMed

Associated data